2008-05-05 23:41:00 -

- Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) today announced its 2008 first quarter earnings release date. Separately, Noven also announced an upcoming investor presentation.

On May 8, 2008, before the U.S. market opens, Noven is scheduled to issue a press release announcing its financial results for the quarter ended March 31, 2008. At 8:30 a.m. ET the same day, a

conference call with management is scheduled to be webcast live at www.noven.com, and thereafter a rebroadcast will be available at the same site for at least two weeks. A taped replay of the call will be available beginning May 8 through May 10 by calling 877-660-6853 (from within the U.S.) or 201-612-7415 (from outside the U.S.) and entering account number 286 and conference ID number 282673.

Noven also announced that Jeffrey F. Eisenberg, Noven's Executive Vice President, is scheduled to present an update on Noven's business and prospects at the Deutsche Bank 33rd Annual Health Care Conference in Boston, MA on Tuesday, May 6 at 8:50 a.m. ET. The presentation will be webcast live at www.noven.com, and a rebroadcast will be available thereafter at the same site.

About Noven

Noven Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products. Noven's business and operations are focused in three principal areas - transdermal drug delivery, the Novogyne joint venture, and its Noven Therapeutics specialty pharmaceutical unit.

For Noven Pharmaceuticals, Inc.
Alina Bowman, 305-253-1916
Investor Relations Coordinator